Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 17Lymphoma, Non-Hodgkin 16Sarcoma 9Leukemia, Myeloid, Acute 9Hodgkin Disease 9Hematologic Neoplasms 9Neuroblastoma 8Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Osteosarcoma 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Breast Neoplasms 5Rhabdoid Tumor 4Retinoblastoma 4Multiple Myeloma 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Wilms Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Myeloproliferative Disorders 3Hepatoblastoma 3Graft vs Host Disease 3

Interventions

Trabectedin 1Radiotherapy 1Mesna 1Ifosfamide 1Doxorubicin 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ichthyosis, X-Linked × Mesna × Clear all
NCT05813327 2026-04-20

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Washington University School of Medicine

Phase 1 Active not recruiting
6 enrolled
Sarcoma

Sarcoma, Ichthyosis, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡